Regulatory Actions

Ajinomoto to Market New Dietary Supplement in the U.S.A. CAPSIATE NATURA Test Sales Start July 16

Published in Medical Letter on the CDC and FDA, August 5th, 2007

Ajinomoto Co., Inc. (Ajinomoto; President and CEO: Norio Yamaguchi; Headquarters: Tokyo, Japan) today announced plans to market a new dietary supplement, Capsiate Natura, in the United States. Capsiate Natura is a dietary supplement with a purified extract of CH-19 Sweet, a unique non-pungent chili pepper, that is selectively bred to contain high levels of capsiate*.

Capsiate Natura has been available in Japan since September 2006. In the U.S., the dietary supplement is being marketed after Ajinomoto's successful completion of the Food and Drug Administration's New Dietary Ingredient (NDI) notification process.

Capsiate Natura will be initially...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2007-08-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry